Search - tctmd.com

Displaying 501 - 520 of 879

Sort: Relevancy | Date

Presentation TCT 2015

TCT 66: Long-term Clinical Outcomes of Percutaneous Coronary Intervention Using Drug-Eluting Stent for Native Coronary Chronic Total Occlusion

Presenter: Sigmund Silber, Philip M. Urban, Pil Hyung Lee

October 13, 2015

Presentation TCT 2015

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

Presenter: Sigmund Silber, Philip M. Urban, David E. Kandzari

October 13, 2015

Presentation TCT 2015

TCT 64: Incidence, Predictors, and Impact of Postdischarge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention

Presenter: Sigmund Silber, Philip M. Urban, Philippe Généreux

October 13, 2015

Presentation TCT 2015

TCT 6: Five-Year Optical Coherence Tomography of Patients With ST-Elevation Myocardial Infarction Treated With Bare-Metal Versus Everolimus-Eluting Stents (the RE-EXAMINATION Study)

Presenter: Eric Boersma, Richard Smalling, Josep Gomez Lara

October 13, 2015

Presentation TCT 2015

TCT 15: Multislice Computed Tomography Assessment of Absorb Bioresorbable Vascular Scaffold in Comparison With Metallic Drug-Eluting Stents Data From the ABSORB Japan Trial

Presenter: Stephen G. Ellis, Lorenz Raber, Kengo Tanabe

October 13, 2015

Presentation TCT 2015

TCT 63: One-Year Results of the REMEDEE Registry Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered Stent in a Multicenter, Prospective Postmarket Registry

Presenter: Sigmund Silber, Philip M. Urban, Robert de Winter

October 13, 2015

Presentation TCT 2015

TCT 47: Comparative Optical Coherent Tomographic Analysis of In-Stent Neoatherosclerosis Between First- and Second-Generation Drug-Eluting Stents

Presenter: Stephan Achenbach, Marc D. Feldman, Mineok Chang

October 13, 2015

Presentation TCT 2015

TCT 62: Predicting Value of Platelet Reactivity on Bleeding and Major Adverse Cardiac Events in Eastern Asian Percutaneous Coronary Intervention Patients

Presenter: Sigmund Silber, Philip M. Urban, Wenyao Wang

October 13, 2015

Presentation TCT 2015

TCT 76: Six Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Sirolimus-Eluting Stents for Bifurcation Lesions Insights From the I-LOVE-IT 2 Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Bo Xu

October 13, 2015

Presentation TCT 2015

TCT 19: Two-Year Clinical Outcomes and Chest Pain in 1,811 All-Comer Patients, Treated for Bifurcated Versus Nonbifurcated Lesions With Highly Deliverable Drug-Eluting Coronary Stents

Presenter: Eric A. Cohen, Truls Råmunddal, Liefke van der Heijden

October 13, 2015

Presentation TCT 2015

TCT 60: Long Coronary Lesions Treated With a Bioresorbable-Polymer Drug-Eluting Stent Experience From eNOBORI Registry

Presenter: Sigmund Silber, Philip M. Urban, Evgeny Kretov

October 13, 2015

Presentation TCT 2015

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

Presenter: Sigmund Silber, Philip M. Urban, Sorin J. Brener

October 13, 2015

News Conference News TCT 2015

Trial Results Often Struggle to Keep Pace With Evolving Technology

Nicole Lou

October 13, 2015

News Conference News TCT 2015

Debaters Question Need for Further Stent Innovation

Todd Neale

October 13, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

Presentation TCT 2015

Case 8: Small Vessels - The Svelte Stent

Presenter: Martin B. Leon, Pieter C. Smits, Pieter R. Stella

October 12, 2015

Presentation TCT 2015

Case 7: Very Long Lesions in Tapering Vessels - The BioMime Morph Stent

Presenter: Martin B. Leon, Pieter C. Smits, Teguh Santoso

October 12, 2015

Presentation TCT 2015

Case 6: Acute Myocardial Infarction or Thrombus Containing Lesions - The MGuard Prime Stent

Presenter: Martin B. Leon, Pieter C. Smits, Chaim S. Lotan

October 12, 2015

Presentation TCT 2015

Case 5: Bifurcations or Left Main - The Tryton Stent

Presenter: Martin B. Leon, Pieter C. Smits, Robert-Jan van Geuns

October 12, 2015

Presentation TCT 2015

Case 4:Bifurcations or Left Main - The Stentys Stent

Presenter: Martin B. Leon, Pieter C. Smits, Carlo Briguori

October 12, 2015

Advertisement

TCT 66: Long-term Clinical Outcomes of Percutaneous Coronary Intervention Using Drug-Eluting Stent for Native Coronary Chronic Total Occlusion

TCT 65: Two-Year Outcomes in Real-World Patients Treated With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent in the PROMUS Element Plus US Postapproval Study (PE-Plus PAS)

TCT 64: Incidence, Predictors, and Impact of Postdischarge Bleeding Compared to Myocardial Infarction After Percutaneous Coronary Intervention

TCT 6: Five-Year Optical Coherence Tomography of Patients With ST-Elevation Myocardial Infarction Treated With Bare-Metal Versus Everolimus-Eluting Stents (the RE-EXAMINATION Study)

TCT 15: Multislice Computed Tomography Assessment of Absorb Bioresorbable Vascular Scaffold in Comparison With Metallic Drug-Eluting Stents Data From the ABSORB Japan Trial

TCT 63: One-Year Results of the REMEDEE Registry Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered Stent in a Multicenter, Prospective Postmarket Registry

TCT 47: Comparative Optical Coherent Tomographic Analysis of In-Stent Neoatherosclerosis Between First- and Second-Generation Drug-Eluting Stents

TCT 62: Predicting Value of Platelet Reactivity on Bleeding and Major Adverse Cardiac Events in Eastern Asian Percutaneous Coronary Intervention Patients

TCT 76: Six Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Sirolimus-Eluting Stents for Bifurcation Lesions Insights From the I-LOVE-IT 2 Trial

TCT 19: Two-Year Clinical Outcomes and Chest Pain in 1,811 All-Comer Patients, Treated for Bifurcated Versus Nonbifurcated Lesions With Highly Deliverable Drug-Eluting Coronary Stents

TCT 60: Long Coronary Lesions Treated With a Bioresorbable-Polymer Drug-Eluting Stent Experience From eNOBORI Registry

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

Trial Results Often Struggle to Keep Pace With Evolving Technology

Debaters Question Need for Further Stent Innovation

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

Case 8: Small Vessels - The Svelte Stent

Case 7: Very Long Lesions in Tapering Vessels - The BioMime Morph Stent

Case 6: Acute Myocardial Infarction or Thrombus Containing Lesions - The MGuard Prime Stent

Case 5: Bifurcations or Left Main - The Tryton Stent

Case 4:Bifurcations or Left Main - The Stentys Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content